{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T10:06:24Z","timestamp":1792058784804,"version":"4.4.0"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,9,19]],"date-time":"2014-09-19T00:00:00Z","timestamp":1411084800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"DOI":"10.13039\/501100000278","name":"Department for International Development, UK Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000278","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008196","name":"M\u00e9decins Sans Fronti\u00e8res","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.ejps.2014.09.006","type":"journal-article","created":{"date-parts":[[2014,9,27]],"date-time":"2014-09-27T15:32:38Z","timestamp":1411831958000},"page":"147-155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["In vitro metabolism, disposition, preclinical pharmacokinetics and prediction of human pharmacokinetics of DNDI-VL-2098, a potential oral treatment for Visceral Leishmaniasis"],"prefix":"10.1016","volume":"65","author":[{"given":"Rao","family":"Mukkavilli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakir","family":"Pinjari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavesh","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shankar","family":"Sengottuvelan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subodh","family":"Mondal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajit","family":"Gadekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manas","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jignesh","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lavanya","family":"Pothuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gopu","family":"Chandrashekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabhakar","family":"Koiram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanukrishnan","family":"Harisudhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ansari","family":"Moinuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Launay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nimish","family":"Vachharajani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikram","family":"Ramanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5334-6633","authenticated-orcid":false,"given":"Denis","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2014.09.006_b0035","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S1367-5931(00)00228-3","article-title":"Prediction of pharmacokinetic properties using experimental approaches during early drug discovery","volume":"5","author":"Chaturvedi","year":"2001","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.ejps.2014.09.006_b0050","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1023\/A:1018943613122","article-title":"Physiological parameters in laboratory animals and humans","volume":"10","author":"Davies","year":"1993","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2014.09.006_b0060","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1476-5381.2010.01040.x","article-title":"Comparative bioactivation of the novel anti-tuberculosis agent PA-824 in Mycobacteria and a subcellular fraction of human liver","volume":"162","author":"Dogra","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejps.2014.09.006_b0080","unstructured":"Flockhart, D.A., 2007. Drug Interactions: Cytochrome P450 Drug Interaction Table. Indiana University School of Medicine. <http:\/\/medicine.iupui.edu\/clinpharm\/ddis\/table.asp>."},{"key":"10.1016\/j.ejps.2014.09.006_b0030","unstructured":"Gupta, S. et al., 2013. Nitroimidazo-oxazole compound DNDi-VL-2098 as a candidate for oral treatment of Visceral Leishmaniasis. In: Proceeding of: 5th International symposium on Drug Development for Orphan-Neglected Diseases (CTDDR-2013), Abs. No. P-75, pp. 134."},{"key":"10.1016\/j.ejps.2014.09.006_b0075","unstructured":"Harisudhan, T. et al., 2011. Preclinical pharmacokinetics and prediction of human PK of DNDI-VL-2098, a potential oral treatment for visceral leishmaniasis. In: Poster presented at AAPS."},{"key":"10.1016\/j.ejps.2014.09.006_b0055","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.addr.2007.05.015","article-title":"Application of allometric principles for the prediction of pharmacokinetics in human and veterinary drug development","volume":"59","author":"Mahmood","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2014.09.006_b0040","doi-asserted-by":"crossref","first-page":"887","DOI":"10.3109\/00498259609052491","article-title":"Interspecies scaling: predicting clearance of drugs in humans: three different approaches","volume":"26","author":"Mehmood","year":"1996","journal-title":"Xenobiotica"},{"key":"10.1016\/j.ejps.2014.09.006_b0015","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1473-3099(05)70296-6","article-title":"Treatment options for visceral leishmaniasis: a systematic review of clinical studies done in India, 1980\u20132004","volume":"5","author":"Olliaro","year":"2005","journal-title":"Lancet. Infect. Dis"},{"key":"10.1016\/j.ejps.2014.09.006_b0065","unstructured":"Rao, M. et al. 2011. In-vitro metabolism and disposition of DNDI-VL-2098, a potential treatment for visceral leishmaniasis. In: Poster Presented at AAPS."},{"issue":"1","key":"10.1016\/j.ejps.2014.09.006_b0020","doi-asserted-by":"crossref","first-page":"e584","DOI":"10.1371\/journal.pntd.0000584","article-title":"Control of visceral leishmaniasis in Latin America \u2014 a systematic review","volume":"4","author":"Romero","year":"2010","journal-title":"PLoS Neglected Tropical Diseases"},{"key":"10.1016\/j.ejps.2014.09.006_b0045","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/j.1476-5381.2009.00267.x","article-title":"To scale or not to scale: the principles of dose extrapolation","volume":"157","author":"Sharma","year":"2009","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.ejps.2014.09.006_b0005","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1086\/318121","article-title":"Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic center","volume":"31","author":"Sundar","year":"2000","journal-title":"Clin. Infect. Dis."},{"issue":"4","key":"10.1016\/j.ejps.2014.09.006_b0010","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/cid\/cis474","article-title":"Efficacy of miltefosine in the treatment of visceral leishmaniasis in India after a decade of use","volume":"55","author":"Sundar","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejps.2014.09.006_b0025","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1473-3099(10)70011-6","article-title":"Combination therapy for visceral leishmaniasis","volume":"10","author":"Van Griensven","year":"2010","journal-title":"Lancet. Infect. Dis"},{"key":"10.1016\/j.ejps.2014.09.006_b0070","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J. Med. Chem."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098714003479?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098714003479?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T11:45:21Z","timestamp":1760528721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098714003479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":16,"alternative-id":["S0928098714003479"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2014.09.006","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro metabolism, disposition, preclinical pharmacokinetics and prediction of human pharmacokinetics of DNDI-VL-2098, a potential oral treatment for Visceral Leishmaniasis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2014.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}